KKR Not Immune to Private-Credit Headwinds -- Market Talk

Dow Jones
03/20

0746 GMT - KKR isn't immune to the headwinds facing the private-credit market, writes Morningstar's Greggory Warren in a note. Issues around liquidity in private-credit funds are likely to hit fundraising efforts and lead to increased redemption requests in the medium term, he says. While the alternative asset manager's exposure to private credit is far less than that of its peers Blue Owl and Ares, the company has enough private-credit exposure to weigh on it for the next several years, he adds. Morningstar cuts its fair-value estimate on KKR to $115 from $140, citing likely lower fundraising and higher redemptions for KKR's credit and liquid strategies segment. However, its shares are still moderately undervalued even with the fair-value estimate change, the analyst adds. Shares last closed flat at $90.60.(megan.cheah@wsj.com)

 

(END) Dow Jones Newswires

March 20, 2026 03:46 ET (07:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10